ENvue Medical, Inc.
FEED
$0.83
$0.00-0.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -291.10% | -374.01% | -98.93% | -171.63% | -55.81% |
| Total Depreciation and Amortization | 5,668.42% | 89,600.00% | 63,800.00% | 38,100.00% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,012.18% | 1,132.39% | -907.31% | -230.69% | -46.44% |
| Change in Net Operating Assets | -75.26% | 127.22% | 728.08% | 1,489.62% | 597.89% |
| Cash from Operations | -276.25% | -272.50% | -194.59% | -165.08% | -10.03% |
| Capital Expenditure | -928.57% | -1,900.00% | -1,133.33% | -200.00% | -600.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -151.06% | 3,033.33% | 3,800.00% | 4,733.33% | 14,200.00% |
| Total Debt Issued | -41.90% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 82,367.86% | 68,439.29% | 61,460.71% | -66.96% | -99.34% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,239.30% | 1,278,500.00% | 1,281,900.00% | 85.55% | -75.07% |
| Foreign Exchange rate Adjustments | 109.09% | 100.00% | 42.86% | 75.00% | 75.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 179.28% | 238.36% | 328.65% | -1.41% | -276.68% |